Literature DB >> 17620103

Corticosteroids, 11beta-hydroxysteroid dehydrogenase isozymes and the rabbit choroid plexus.

A J Sinclair1, C U Onyimba, P Khosla, N Vijapurapu, J W Tomlinson, M A Burdon, P M Stewart, P I Murray, E A Walker, S Rauz.   

Abstract

The epithelial cells of the choroid plexus (CP) are responsible for cerebrospinal fluid (CSF) secretion into the ventricles of the brain. The balance between CSF production and drainage, in part, facilitates a normal intracranial pressure. The secretion of Na(+) and anions by the CP creates an osmotic gradient driving water into the ventricles. This is opposite to classical Na(+) transporting tissues, such as the kidney, where Na(+) and water reabsorption is mediated by 11beta-hydroxysteroid dehydrogenase type 2 that protects the mineralocorticoid receptor by abrogating active cortisol to inactive cortisone. In the human ocular ciliary epithelium, Na(+) and water secretion is dependent on a novel mediator of ciliary epithelial Na(+) transport, 11beta-HSD type 1 (11beta-HSD1), that generates intraocular cortisol. In a mechanism analogous to that of the embryologically related ocular ciliary epithelium, we propose that autocrine regulation of intracranial cortisol is dependent on 11beta-HSD1 expression in the CP epithelial cells. By conducting immunolocalisation studies on brains from New Zealand White Albino rabbits, we defined the expression of 11beta-HSD1 in the secretory CP epithelial cells. Enzyme assays performed on intact rabbit CP whole tissue explants confirmed predominant 11beta-HSD1 activity, generating cortisol that was inhibited by glycyrrhetinic acid (an 11beta-HSD inhibitor). Using the real time-polymerase chain reaction, rabbit CP tissue was found to express levels of 11beta-HSD1, glucocorticoid receptor alpha and serum and glucocorticoid-regulated kinase 1 mRNA comparable to that expressed in rabbit ocular ciliary body, thereby highlighting the similarity between these two tissues. Furthermore, an enzyme-linked immunosorbent assay of rabbit CSF revealed a median cortisol concentration of 1.7 nmol/l (range 1.4-4.3 nmol/l, n = 9). Our data have identified a functional 11beta-HSD1 within the CP, mediating intracranial cortisol bioavailability. Expression of 11beta-HSD1 may be fundamental in the regulation of CSF secretion and the local generation of cortisol may represent a pathophysiological mechanism underlying cortisol-dependent neuroendocrine diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17620103     DOI: 10.1111/j.1365-2826.2007.01569.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  14 in total

1.  Stress and glucocorticoids increase transthyretin expression in rat choroid plexus via mineralocorticoid and glucocorticoid receptors.

Authors:  A Martinho; I Gonçalves; M Costa; C R Santos
Journal:  J Mol Neurosci       Date:  2012-02-28       Impact factor: 3.444

Review 2.  Pediatric Pseudotumor Cerebri Syndrome: Diagnosis, Classification, and Underlying Pathophysiology.

Authors:  Claire A Sheldon; Grace L Paley; Shannon J Beres; Shana E McCormack; Grant T Liu
Journal:  Semin Pediatr Neurol       Date:  2017-04-07       Impact factor: 1.636

3.  Glucocorticoids regulate metallothionein-1/2 expression in rat choroid plexus: effects on apoptosis.

Authors:  A Martinho; I Gonçalves; C R Santos
Journal:  Mol Cell Biochem       Date:  2013-01-06       Impact factor: 3.396

Review 4.  An integrated mechanism of pediatric pseudotumor cerebri syndrome: evidence of bioenergetic and hormonal regulation of cerebrospinal fluid dynamics.

Authors:  Claire A Sheldon; Young Joon Kwon; Grant T Liu; Shana E McCormack
Journal:  Pediatr Res       Date:  2014-11-24       Impact factor: 3.756

5.  Amphetamine withdrawal differentially affects hippocampal and peripheral corticosterone levels in response to stress.

Authors:  Brenna Bray; Jamie L Scholl; Wenyu Tu; Michael J Watt; Kenneth J Renner; Gina L Forster
Journal:  Brain Res       Date:  2016-05-18       Impact factor: 3.252

Review 6.  Guide to preclinical models used to study the pathophysiology of idiopathic intracranial hypertension.

Authors:  Zerin Alimajstorovic; Connar S J Westgate; Rigmor H Jensen; Sajedeh Eftekhari; James Mitchell; Vivek Vijay; Senali Y Seneviratne; Susan P Mollan; Alexandra J Sinclair
Journal:  Eye (Lond)       Date:  2020-01-02       Impact factor: 3.775

Review 7.  Idiopathic intracranial hypertension; research progress and emerging themes.

Authors:  Ruchika Batra; Alexandra Sinclair
Journal:  J Neurol       Date:  2013-10-02       Impact factor: 4.849

8.  11βHSD1 Inhibition with AZD4017 Improves Lipid Profiles and Lean Muscle Mass in Idiopathic Intracranial Hypertension.

Authors:  Rowan S Hardy; Hannah Botfield; Keira Markey; James L Mitchell; Zerin Alimajstorovic; Connar S J Westgate; Michael Sagmeister; Rebecca J Fairclough; Ryan S Ottridge; Andreas Yiangou; Karl-Heinz H Storbeck; Angela E Taylor; Lorna C Gilligan; Wiebke Arlt; Paul M Stewart; Jeremy W Tomlinson; Susan P Mollan; Gareth G Lavery; Alexandra J Sinclair
Journal:  J Clin Endocrinol Metab       Date:  2021-01-01       Impact factor: 5.958

Review 9.  Idiopathic intracranial hypertension, hormones, and 11β-hydroxysteroid dehydrogenases.

Authors:  Keira A Markey; Maria Uldall; Hannah Botfield; Liam D Cato; Mohammed A L Miah; Ghaniah Hassan-Smith; Rigmor H Jensen; Ana M Gonzalez; Alexandra J Sinclair
Journal:  J Pain Res       Date:  2016-04-19       Impact factor: 3.133

10.  Idiopathic intracranial hypertension as a presenting sign of adrenal insufficiency.

Authors:  Sandra Shenouda; Khaled Al-Farawi; Jenna Dolan; Susan L Flesher
Journal:  SAGE Open Med Case Rep       Date:  2018-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.